The first step to cloning the receptor required identifying and extracting the right genetic sequence from DNA
Again, all of those available, completely zero cost
European Journal of Pharmacology, 833, 274289
Indications Where BPC-157 Alone Makes Sense Consider BPC-157 without Thymosin Alpha-1 in the following scenarios: Acute or subacute tendon or ligament injuries where immune function is intact Post-surgical GI healing, particularly after bowel resection or ulcer repair Inflammatory bowel conditions in a patient without concurrent immunosuppression Musculoskeletal overuse injuries in otherwise healthy athletes In these cases, adding Thymosin Alpha-1 adds cost and injection burden without a clear mechanistic benefit
According to one study, patients with severe cases of COVID-19 often present with comorbidities that have already done significant damage to the endothelium
Furthermore, dihexa is thought to cross the blood-brain barrier effectively, delivering its benefits directly to the central nervous system, which is a significant advantage in neurological therapies